$ Value
$0
Shares
143,985
Price
$0
Filed
Mar 9
Insider
Name
FRATES JAMES M
Title
Chief Financial Officer
CIK
0001235598
Roles
Transaction Details
Transaction Date
2026-03-05
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
143,985
Footnotes
The reported transaction involves the Reporting Person's receipt of a restricted stock unit ("RSU") award. The RSUs shall vest in 4 equal annual installments, with the first installment vesting on March 1, 2027, subject to the Reporting Person's continued service to the Issuer through each such vesting date. | Shares held by the JAMES M. FRATES 2025 GRAT NO 1 U/A DTD 12/12/2025, for which the Reporting Person serves as trustee and is the sole annuitant. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. | Shares held by the James M. Frates 2024 Grantor Retained Annuity Trust No. 1, for which the Reporting Person serves as trustee and is the sole annuitant. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. | Shares held by the FRATES FAMILY 2013 IRREV TRUST, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. | 25% of the shares subject to the option shall vest and become exercisable on March 1, 2027, and the remaining shares shall vest monthly over the remaining 36 months, subject to the Reporting Person's continuous service to the Issuer through each such vesting date.
Filing Info
FRATES JAMES M's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-05 | AMLX | A | $0 |
| 2026-03-05 | AMLX | A | $0 |
| 2026-03-02 | AMLX | ▼ | $115K |
| 2026-02-02 | AMLX | ▼ | $52K |
| 2026-01-06 | AMLX | ▼ | $37K |
| 2025-09-30 | AMLX | ▼ | $155K |
| 2025-07-31 | SAGE | U | — |
| 2025-07-31 | SAGE | D | — |
| 2025-07-31 | SAGE | D | — |
| 2025-06-11 | SAGE | A | $0 |
Other Insiders at AMLX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
FRATES JAMES M
Chief Financial Officer
|
— | $167K | 2026-03-05 |
|
Bedrosian Camille L
Chief Medical Officer
|
— | $94K | 2026-03-05 |
|
Klee Justin B.
Co-Chief Executive Officer
|
— | $651K | 2026-03-05 |
|
Cohen Joshua B
Co-Chief Executive Officer
|
— | $652K | 2026-03-05 |
|
Mazzariello Gina
Chief Legal Officer
|
— | $198K | 2026-03-05 |